The weekly litigation news digest is live. Subscribe now

IP Verse

Targeted Rna Editing - EP3234134

The patent EP3234134 was granted to Proqr Therapeutics II on May 27, 2020. The application was filed on Dec 17, 2015 under application number EP15813826A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3234134

PROQR THERAPEUTICS II
Application Number
EP15813826A
Filing Date
Dec 17, 2015
Status
Granted And Under Opposition
Apr 24, 2020
Publication Date
May 27, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MARGARET DIXONFeb 25, 2021MAIWALDADMISSIBLE
STRAWMANFeb 25, 2021LEONARDADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONEP3323890
EXAMINATIONWO2017050306
INTERNATIONAL-SEARCH-REPORTWO2014011053
OPPOSITIONEP3353299
OPPOSITIONUS9650627
OPPOSITIONWO2005094370
OPPOSITIONWO2014011053

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents